Differential Effects of “Vaping” on Lipid and Glucose Profiles and Liver Metabolic Markers in Obese Versus Non-obese Mice.

Introduction:
This article published in Frontiers in Physiology investigates the effects of e-cigarette vapor exposure on metabolic profiles in mice fed with either a chow or high-fat diet (hFD). The study specifically looked at the impact of e-cigarette vapor on glucose tolerance, blood lipid levels, and liver metabolic markers.

Key Points:

* The study used male Balb/c mice and exposed them to nicotine-containing or nicotine-free e-vapor for six weeks.
* hFD consumption increased body weight, retroperitoneal and epididymal fat mass, blood non-esterified fatty acids (NEFa) and triglycerides levels, and hepatic fat deposition.
* Exposure to nicotine-containing e-vapor improved glucose clearance in hFD-fed mice, while nicotine-free e-vapor reduced retroperitoneal fat mass.
* Both nicotine-containing and nicotine-free e-vapor increased NEFa levels and liver triglycerides in chow-fed mice.
* hFD consumption reduced the expression of PPaRγ, a key regulator of insulin sensitivity, and increased the expression of glucose transporter 2 (Glut2) and 4 (Glut4).
* E-vapor exposure increased the expression of Glut2, but not Glut4, and had no effect on PPaRγ expression.
* The study suggests that e-cigarette vapor exposure may have differential effects on metabolic profiles depending on the diet.

Main Message:
The study highlights the importance of considering dietary factors when evaluating the impact of e-cigarette vapor exposure on metabolic profiles. The study suggests that while nicotine-containing e-vapor may have beneficial effects on glucose tolerance in hFD-fed mice, both nicotine-containing and nicotine-free e-vapor may have unfavorable effects on lipid metabolism in chow-fed mice. Further studies are needed to confirm these findings and to evaluate the long-term effects of e-cigarette vapor exposure on metabolic health.

Chen h, Li G, Chan YL, et al. Differential Effects of “Vaping” on Lipid and Glucose Profiles and Liver Metabolic Markers in Obese Versus Non-obese Mice. Frontiers in physiology. 2021;12:755124. doi:10.3389/fphys.2021.755124